Clinical Trial Detail

NCT ID NCT02520063
Title Preoperative Combination of Letrozole, Everolimus, and TRC105 in Postmenopausal Hormone-Receptor Positive and Her2 Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements yes
Sponsors University of Alabama at Birmingham
Indications

Her2-receptor negative breast cancer

Therapies

Carotuximab + Everolimus + Letrozole

Age Groups: senior adult

Additional content available in CKB BOOST